HLA-A*0201 & B2M & PRAME (SLLQHLIGL) Product List
You Have Viewed 0 Of 0 Results
Clinical Drug Information
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| NM26-2198 | NM-26-2198 | Phase 1 Clinical | Kaken Pharmaceutical Co Ltd, Numab Therapeutics Ag | Inflammation; Dermatitis, Atopic | Details |